Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04427878
Other study ID # 20-PP-15
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2020
Est. completion date July 9, 2021

Study information

Verified date June 2020
Source Centre Hospitalier Universitaire de Nice
Contact Vanina OLIVERI, PM
Phone 0033 4 92 03 42 54
Email oliveri.v@chu-nice.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Resident cells of human adipose tissue express ACE2 and DPP4, receptors for SARS-Cov2. The hypothesis is that the virus may enter and spread in fat depots.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 5
Est. completion date July 9, 2021
Est. primary completion date July 9, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female = 18 years old

- Patients testing positive for Covid19

- Patients affiliated to social security

- Signing of free and informed consent

Exclusion Criteria:

- Vulnerable persons (- minors,

- adults under guardianship or curatorship,

- pregnant women,

- persons deprived of their liberty,

- persons who do not master the French language)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
biopsies of subcutaneous adipose tissue
Two 4mm punch biopsies of subcutaneous abdominal or thight adipose tissue

Locations

Country Name City State
France CHU de Nice Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The presence of SARS-CoV2 in adipose tissue of Covid19 patients RT-qPCR for SARS-Cov-2 from RNAs and by immunodetection Day 0
Secondary The expression of inflammatory cytokines in adipose tissue of Covid19 patients RT-qPCR for IL6 Day 0
Secondary The expression of inflammatory cytokines in adipose tissue of Covid19 patients RT-qPCR for IL1 Day 0
Secondary The expression of inflammatory cytokines in adipose tissue of Covid19 patients RT-qPCR for TNFa Day 0
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04592835 - To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 Phase 1
Not yet recruiting NCT05083104 - Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
Completed NCT05162534 - Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
Completed NCT04853979 - Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure N/A
Completed NCT05369676 - To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 Phase 1/Phase 2
Completed NCT05901337 - Cupping Therapy on Immune System in Post Covid -19 N/A
Recruiting NCT06349720 - Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
Completed NCT04407130 - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. Phase 2
Terminated NCT04541485 - To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) Phase 1
Withdrawn NCT04374903 - Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients N/A